IBS vs Ultima

Ultima (ULTIMA) is 35.8× the size of IBS (IBS) by market capitalisation. Over the past 30 days, IBS is ahead by 41.0 percentage points (IBS -0.2% against ULTIMA -41.2%). Their daily returns move barely in opposite directions (correlation -0.10 across 22 shared trading days). ULTIMA has been the more volatile of the two, at 52% annualised against IBS's 6%.

Correlation: -0.10
Size ratio: 1 : 35.8
Ahead over 30 days: IBS

IBSIBS

$0.000684

24h: -0.28%
Market cap: $2.75M
Volume 24h: $55,927
Volatility (ann.): 6%

UltimaULTIMA

$1,164.16

24h: +0.98%
Market cap: $98.62M
Volume 24h: $5.57M
Volatility (ann.): 52%

IBS 2.7%Share of the two combined market caps97.3% ULTIMA

Performance

IBSULTIMA

7 days-1.47%-6.81%IBS
30 days-0.16%-41.19%IBS

Correlation

-0.10over 22 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: insufficient data90d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	IBS	ULTIMA
Max drawdown (400d)	-2.1%	-51.6%
Risk-adjusted return (90d)	-0.03	-0.96

Relative strength over 90 days: IBS outperformed ULTIMA by 27.1% — measured on the IBS/ULTIMA ratio, so it holds regardless of market direction.

IBS →Ultima →